Cite
HARVARD Citation
Hirose, T. et al. (2016). Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer. Lung cancer. pp. 69-76. [Online].